Kimberly-Clark Ebola Virus Disease (EVD) Precautions Brief
This document includes information about modes of transmission, personal protective guidance, environmental disinfection protocols, and laboratory safety.
EBOLA: The Ebola virus is a lipid enveloped virus in the family Filoviridae. Members of this family also include Marburg, Lassa, and other viruses that cause hemorrhagic fever, a group of illnesses that damage the vascular system and in severe cases, lead to bleeding under the skin, in internal organs or from body orifices (e.g. mouth, eyes and ears)1. Infection with the Ebola virus is now referred to as: Ebola virus disease (EVD)2. There is a diagnostic test to determine if the patient has EVD. There is no current FDA approved effective medication or treatment for those who become infected with Ebola other than supportive hydration, electrolyte balancing and oxygen. The death rate of those infected is between 50-90%. There is no vaccine or preventative treatment.
Person-to-person transmission occurs by very close personal contact with an infected individual or with their body fluids during the late stages of infection or after their death 3,4. During the care of an infected individual, spread of the virus can occur through contact with infected body fluids on the patient, on their clothes or bedding, on surfaces such as bedrails, side tables, the floor, or on reused unsterilized syringes, needles, thermometers or other virus-contaminated medical equipment. Humans may also be infected by handling sick or dead non-human primates and are also at risk when handling the bodies of deceased humans in preparation for funerals 5,6.
Click here to download the complete Kimberly-Clark Ebola Virus Disease (EVD) Precautions Brief.
Click here to download the Kimberly-Clark Personal Protection Solutions Guide